Minor
Hybrid CATT1 · Cadisegliatin as Adjunctive Therapy to Insulin · Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Primary completion pushed from Apr 2027 to Jun 2027
vTv TherapeuticsPhase 2 NCT07616206 Registry history of NCT07616206 on ClinicalTrials.gov (opens the registry)